Amylyx Pharmaceuticals
AMLX
AMLX
95 hedge funds and large institutions have $1.05B invested in Amylyx Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 38 increasing their positions, 20 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
58% more call options, than puts
Call options by funds: $94.4M | Put options by funds: $59.8M
22% more funds holding
Funds holding: 78 → 95 (+17)
18.19% more ownership
Funds ownership: 45.48% → 63.67% (+18%)
Holders
95
Holding in Top 10
6
Calls
$94.4M
Puts
$59.8M
Top Buyers
| 1 | +$70.9M | |
| 2 | +$54.4M | |
| 3 | +$44.7M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$37.4M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$32.4M |
Top Sellers
| 1 | -$39.4M | |
| 2 | -$26M | |
| 3 | -$18M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$16.1M |
| 5 |
TCM
Tybourne Capital Management
Hong Kong
|
-$14.8M |